Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)

Wen Chi Yang; Ya Fang Chen; Chi Cheng Yang; Pei Fang Wu; Hsing Min Chan; Jenny Ling Yu Chen; Guann Yiing Chen; Jason Chia Hsien Cheng; Sung Hsin Kuo; Feng Ming Hsu

doi:10.1093/neuonc/noab176

Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)

Wen Chi Yang
, Ya Fang Chen
, Chi Cheng Yang
, Pei Fang Wu
, Hsing Min Chan
, Jenny Ling Yu Chen
, Guann Yiing Chen
, Jason Chia Hsien Cheng
, Sung Hsin Kuo
, Feng Ming Hsu^*

^*Corresponding author for this work

Department of Occupational Therapy

National Taiwan University

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the originally published version of this manuscript, the affiliation 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.)' was incomplete. It has now been updated as follows: 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.), National Taiwan University College of Medicine, Taipei, Taiwan'. In addition, in Table 1, item Primary cancer of the HA-WBRT group, the number of "Others: 3.0% (33)", has been corrected to "Others: 3.0% (1)".

Original language	English
Pages (from-to)	2125
Number of pages	1
Journal	Neuro-Oncology
Volume	23
Issue number	12
DOIs	https://doi.org/10.1093/neuonc/noab176
State	Published - 01 12 2021

Bibliographical note

Publisher Copyright:
© 2021 Oxford University Press. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/neuonc/noab176

Fingerprint

Dive into the research topics of 'Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)'. Together they form a unique fingerprint.

Cite this

Yang, W. C., Chen, Y. F., Yang, C. C., Wu, P. F., Chan, H. M., Chen, J. L. Y., Chen, G. Y., Cheng, J. C. H., Kuo, S. H., & Hsu, F. M. (2021). Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193). Neuro-Oncology, 23(12), 2125. https://doi.org/10.1093/neuonc/noab176

@article{eaefd6b081164acea51730f1509617d6,

title = "Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)",

abstract = "In the originally published version of this manuscript, the affiliation 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.)' was incomplete. It has now been updated as follows: 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.), National Taiwan University College of Medicine, Taipei, Taiwan'. In addition, in Table 1, item Primary cancer of the HA-WBRT group, the number of {"}Others: 3.0\% (33){"}, has been corrected to {"}Others: 3.0\% (1){"}.",

author = "Yang, \{Wen Chi\} and Chen, \{Ya Fang\} and Yang, \{Chi Cheng\} and Wu, \{Pei Fang\} and Chan, \{Hsing Min\} and Chen, \{Jenny Ling Yu\} and Chen, \{Guann Yiing\} and Cheng, \{Jason Chia Hsien\} and Kuo, \{Sung Hsin\} and Hsu, \{Feng Ming\}",

year = "2021",

month = dec,

day = "1",

doi = "10.1093/neuonc/noab176",

language = "英语",

volume = "23",

pages = "2125",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

Yang, WC, Chen, YF, Yang, CC, Wu, PF, Chan, HM, Chen, JLY, Chen, GY, Cheng, JCH, Kuo, SH & Hsu, FM 2021, 'Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)', Neuro-Oncology, vol. 23, no. 12, pp. 2125. https://doi.org/10.1093/neuonc/noab176

Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193). / Yang, Wen Chi; Chen, Ya Fang; Yang, Chi Cheng et al.
In: Neuro-Oncology, Vol. 23, No. 12, 01.12.2021, p. 2125.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)

AU - Yang, Wen Chi

AU - Chen, Ya Fang

AU - Yang, Chi Cheng

AU - Wu, Pei Fang

AU - Chan, Hsing Min

AU - Chen, Jenny Ling Yu

AU - Chen, Guann Yiing

AU - Cheng, Jason Chia Hsien

AU - Kuo, Sung Hsin

AU - Hsu, Feng Ming

PY - 2021/12/1

Y1 - 2021/12/1

N2 - In the originally published version of this manuscript, the affiliation 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.)' was incomplete. It has now been updated as follows: 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.), National Taiwan University College of Medicine, Taipei, Taiwan'. In addition, in Table 1, item Primary cancer of the HA-WBRT group, the number of "Others: 3.0% (33)", has been corrected to "Others: 3.0% (1)".

AB - In the originally published version of this manuscript, the affiliation 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.)' was incomplete. It has now been updated as follows: 'Graduate Institute of Oncology (W-C.Y., J.C-H.C., S-H.K., F-M.H.) and Cancer Research Center (W-C.Y., J.C-H.C., S-H.K., F-M.H.), National Taiwan University College of Medicine, Taipei, Taiwan'. In addition, in Table 1, item Primary cancer of the HA-WBRT group, the number of "Others: 3.0% (33)", has been corrected to "Others: 3.0% (1)".

UR - https://www.scopus.com/pages/publications/85122546059

U2 - 10.1093/neuonc/noab176

DO - 10.1093/neuonc/noab176

M3 - 评论/辩论

C2 - 34363389

AN - SCOPUS:85122546059

SN - 1522-8517

VL - 23

SP - 2125

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 12

ER -

Erratum: Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: A phase II blinded randomized trial (Neuro Oncol (2021) 23:3 (478-486) DOI: 10.1093/neuonc/noaa193)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this